The crosstalk between mTORC2 and BRCA1 arising from their protein interaction is important to understand breast and ovarian cancer susceptibility and improve treatment options based on a patient’s BRCA1 mutation status. This evidence concerns the gene BRCA1 and ovarian cancer.